Eisai Co Ltd Adr Esalf Ceo Haruo Naito On Q2 2018 Results Earnings Call Transcript | Latest News RSS feed

Eisai Co Ltd Adr Esalf Ceo Haruo Naito On Q2 2018 Results Earnings Call Transcript - Latest News


Biogen Inc.: Biogen and Eisai Report Data from Long-Term Extension Phase 1b Study of Investigational Alzheimer's Disease Treatment Aducanumab

Aug. 28, 2018(Nasdaq: BIIB) and Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced results from a recent analysis of the ongoing long-term extension (LTE) Phase 1b study of ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us